CA Patent

CA2904812C — Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

Assigned to Tonix Pharma Holdings Ltd · Expires 2021-07-20 · 5y expired

What this patent protects

The present invention relates to pharmaceutical compositions and methods of manufacturing the same, comprising a eutectic of Cyclobenzaprine HCl and mannitol or Amitriptyline HCl and mannitol.

USPTO Abstract

The present invention relates to pharmaceutical compositions and methods of manufacturing the same, comprising a eutectic of Cyclobenzaprine HCl and mannitol or Amitriptyline HCl and mannitol.

Drugs covered by this patent

cyclobenzaprine-hydrochloride (CYCLOBENZAPRINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2904812C
Jurisdiction: CA
Classification: —
Expires: 2021-07-20
Drug substance claim: No
Drug product claim: No
Assignee: Tonix Pharma Holdings Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.